Trump administration reportedly shortlisting CDC nominees
2026-03-21 12:24:28 ET
More on Pfizer, Moderna, etc.
- Pfizer: I'm Still Expecting A Massive Rebound
- Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation
- Pfizer: Cheap For A Reason
- Pfizer tells shareholders to reject mini-tender offer
- Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
Read the full article on Seeking Alpha
For further details see:
Trump administration reportedly shortlisting CDC nomineesNASDAQ: MRK
MRK Trading
0.76% G/L:
$120.68 Last:
3,323,260 Volume:
$119.07 Open:



